GIMA BIOMARKER Trademark

Trademark Overview


On Tuesday, March 12, 2024, a trademark application was filed for GIMA BIOMARKER with the United States Patent and Trademark Office. The USPTO has given the GIMA BIOMARKER trademark a serial number of 98445113. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Monday, September 23, 2024. This trademark is owned by The 3CPM Company, Inc.. The GIMA BIOMARKER trademark is filed in the Medical Instrument Products category with the following description:

Medical diagnostic apparatus for testing myoelectrical activity; Medical diagnostic apparatus for testing myoelectrical activity incorporating recorded operating system software
gima biomarker

General Information


Serial Number98445113
Word MarkGIMA BIOMARKER
Filing DateTuesday, March 12, 2024
Status638 - NEW APPLICATION - ASSIGNED TO EXAMINER
Status DateMonday, September 23, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMedical diagnostic apparatus for testing myoelectrical activity; Medical diagnostic apparatus for testing myoelectrical activity incorporating recorded operating system software

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, March 12, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameThe 3CPM Company, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSparks Glencoe, MD 21152

Trademark Events


Event DateEvent Description
Tuesday, March 12, 2024NEW APPLICATION ENTERED
Thursday, August 1, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 23, 2024ASSIGNED TO EXAMINER